Union Pacific Corporation Stock Was 9.93% Up On Wednesday

(VIANEWS) – The NYSE ended the session with Union Pacific Corporation (UNP) jumping 9.93% to $236.96 on Wednesday while NYSE jumped 0.2% to $16,418.21. Union Pacific Corporation’s last close was $215.55, 11.06% under its 52-week high of $242.36. About Union Pacific Corporation Union Pacific Corporation, through its subsidiary, Union Pacific Railroad Company, operates in the…

Read More

PAVmed And Snap On The List Of Winners And Losers Of Wednesday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session. The three biggest winners today are PAVmed, Rubius Therapeutics, and Powerbridge Technologies Co., Ltd.. Rank Financial Asset Price Change Updated (EST) 1 PAVmed (PAVMW) 0.03 105.67% 2023-07-25 21:07:07 2 Rubius Therapeutics…

Read More

Sabre Corporation Stock Went Up By Over 32% In The Last 21 Sessions

Sabre Corporation (NASDAQ: SABR) has certainly been making waves in the stock market recently. Its stock prices have experienced a remarkable spike, increasing by 32.9% across 21 sessions despite the NASDAQ’s 0.12% decrease. This shows that the company has been resilient and flourishing in a market that’s been otherwise stagnant. Texas-based travel tech provider’s performance…

Read More

Gevo Stock Bullish Momentum With A 28% Rise In The Last 21 Sessions

Gevo, Inc. (NASDAQ: GEVO), an alternative fuels company specializing in renewables fuels, experienced an impressive 28.24% uptick over 21 sessions; moving from .31 on June 26, 2023, to .68 on Wednesday afternoon — this outpaced NASDAQ’s general downward trend by 0.45% after two consecutive gains were seen on this exchange. Key Business Segments Englewood-based Gevo,…

Read More

FibroGen Stock Bearish By 30% In The Last 21 Sessions

FibroGen Inc., whose shares are traded on San Francisco’s Biopharmaceutical Exchange, recently experienced a significant market event. The shares observed a steep 30.63% decline over 21 sessions, closing at $0.88 at 15:07 EST on Wednesday. Remarkably, this decline mirrored a decrease in the NASDAQ Composite index by 0.311%. FibroGen’s Product Portfolio Having carved a niche…

Read More